• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Ketamine and Electroconvulsive Therapy for Treatment-Refractory Depression.

作者信息

Huang Xing-Bing, Zheng Wei

机构信息

Department of Psychiatry, The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China.

出版信息

Alpha Psychiatry. 2023 Nov 1;24(6):244-246. doi: 10.5152/alphapsychiatry.2023.231358. eCollection 2023 Nov.

DOI:10.5152/alphapsychiatry.2023.231358
PMID:38313444
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10837519/
Abstract
摘要

相似文献

1
Ketamine and Electroconvulsive Therapy for Treatment-Refractory Depression.氯胺酮与电休克治疗难治性抑郁症
Alpha Psychiatry. 2023 Nov 1;24(6):244-246. doi: 10.5152/alphapsychiatry.2023.231358. eCollection 2023 Nov.
2
The Safety, Clinical, and Neurophysiological Effects of Intranasal Ketamine in Patients Who Do Not Respond to Electroconvulsive Therapy: Protocol for a Pilot, Open-Label Clinical Trial.鼻内注射氯胺酮对电休克治疗无反应患者的安全性、临床及神经生理学效应：一项开放性试点临床试验方案
JMIR Res Protoc. 2022 Jan 17;11(1):e30163. doi: 10.2196/30163.
3
Ketamine Augmentation of Electroconvulsive Therapy: A Scoping Review of Dose-Dependent Effects in Major Depressive Disorder.氯胺酮增强电休克治疗：重度抑郁症剂量依赖性效应的范围综述
Cureus. 2023 Jun 7;15(6):e40087. doi: 10.7759/cureus.40087. eCollection 2023 Jun.
4
Electroconvulsive therapy with S-ketamine anesthesia for catatonia in coexisting depression and dementia.电抽搐治疗合并抑郁和痴呆的紧张症伴用 S-氯胺酮麻醉。
Int Psychogeriatr. 2017 Jul;29(7):1223-1225. doi: 10.1017/S104161021700014X. Epub 2017 Feb 22.
5
[Electroconvulsive therapy in treatment resistant depression: What is new?].[难治性抑郁症的电休克治疗：有哪些新进展？]
Psychiatriki. 2021 Dec;32(Supplement I):82-89. doi: 10.22365/jpsych.2021.053.
6
Racemic Ketamine as an Alternative to Electroconvulsive Therapy for Unipolar Depression: A Randomized, Open-Label, Non-Inferiority Trial (KetECT).消旋体氯胺酮作为单相抑郁电抽搐治疗的替代疗法：一项随机、开放标签、非劣效性试验（KetECT）。
Int J Neuropsychopharmacol. 2022 May 27;25(5):339-349. doi: 10.1093/ijnp/pyab088.
7
Potential advantages of ketamine over electroconvulsive therapy in the treatment of nonrefractory severe depression in older patients with multiple medical comorbidities.氯胺酮相对于电抽搐治疗在治疗伴有多种合并症的老年非难治性重度抑郁症患者中的潜在优势。
CNS Spectr. 2023 Jun;28(3):313-318. doi: 10.1017/S1092852922000773. Epub 2022 May 2.
8
Rapid antidepressant effect of ketamine anesthesia during electroconvulsive therapy of treatment-resistant depression: comparing ketamine and propofol anesthesia.氯胺酮麻醉在电抽搐治疗难治性抑郁症中的快速抗抑郁作用：比较氯胺酮和丙泊酚麻醉。
J ECT. 2010 Sep;26(3):223-7. doi: 10.1097/YCT.0b013e3181c3b0aa.
9
Rapid and sustained improvement in treatment-refractory depression through use of acute intravenous ketamine and concurrent transdermal selegiline: A case series.急性静脉注射氯胺酮联合透皮用司来吉兰治疗难治性抑郁症：病例系列研究。
J Affect Disord. 2020 Feb 1;262:40-42. doi: 10.1016/j.jad.2019.10.050. Epub 2019 Oct 31.
10
A randomized, crossover comparison of ketamine and electroconvulsive therapy for treatment of major depressive episodes: a Canadian biomarker integration network in depression (CAN-BIND) study protocol.一项随机、交叉比较氯胺酮与电抽搐治疗重性抑郁发作的研究：加拿大抑郁症生物标志物整合网络研究方案。
BMC Psychiatry. 2020 Jun 2;20(1):268. doi: 10.1186/s12888-020-02672-3.

引用本文的文献

1
Research Progress on the Mechanism of Ketamine in Neuropathic Pain Comorbid Depression.氯胺酮治疗合并抑郁症的神经性疼痛机制的研究进展
Neuropsychiatr Dis Treat. 2025 Aug 9;21:1623-1636. doi: 10.2147/NDT.S534938. eCollection 2025.
2
Identification of Genes in Diagnosing Major Depressive Disorder with Anorexia Through Bioinformatics Analysis.通过生物信息学分析鉴定用于诊断伴有厌食症的重度抑郁症的基因
Neuropsychiatr Dis Treat. 2025 Jul 30;21:1533-1547. doi: 10.2147/NDT.S525882. eCollection 2025.
3
Effects of Binaural Beat Music and Esketamine for ECT in the Treatment of Major Depressive Disorder: A Randomized Controlled Trial Protocol.双耳节拍音乐与艾司氯胺酮辅助电休克治疗重度抑郁症的效果：一项随机对照试验方案
Neuropsychiatr Dis Treat. 2025 Jun 24;21:1249-1260. doi: 10.2147/NDT.S514640. eCollection 2025.
4
Prevalence and Associated Factors of Depression in Patients with Ischaemic Stroke: A Cross-Sectional Study.缺血性脑卒中患者抑郁的患病率及相关因素：一项横断面研究
Neuropsychiatr Dis Treat. 2025 Apr 14;21:875-883. doi: 10.2147/NDT.S514184. eCollection 2025.
5
Disruption of Multimodal Brain Networks and Structural-Functional Coupling in Adolescents with Major Depressive Disorder.重度抑郁症青少年的多模态脑网络及结构-功能耦合中断
Neuropsychiatr Dis Treat. 2025 Apr 9;21:791-798. doi: 10.2147/NDT.S515540. eCollection 2025.
6
Effect of perampanel in reducing depression in patients with focal epilepsy.吡仑帕奈对减轻局灶性癫痫患者抑郁症状的作用。
IBRO Neurosci Rep. 2025 Jan 15;18:257-262. doi: 10.1016/j.ibneur.2025.01.007. eCollection 2025 Jun.
7
The Prevalence of Depression Among Parkinson's Disease Patients in Saudi Arabia: A Cross-Sectional Study.沙特阿拉伯帕金森病患者中抑郁症的患病率：一项横断面研究。
Neuropsychiatr Dis Treat. 2025 Feb 4;21:241-256. doi: 10.2147/NDT.S493629. eCollection 2025.
8
Risk factors for electroconvulsive therapy-induced fever: a retrospective case-control study.电休克治疗所致发热的危险因素：一项回顾性病例对照研究。
Front Psychiatry. 2025 Jan 24;15:1530533. doi: 10.3389/fpsyt.2024.1530533. eCollection 2024.
9
Psilocybin for major depressive disorder: a systematic review of randomized controlled studies.用于治疗重度抑郁症的裸盖菇素：随机对照研究的系统评价
Front Psychiatry. 2024 Sep 23;15:1416420. doi: 10.3389/fpsyt.2024.1416420. eCollection 2024.
10
Unveiling the Interplay Between Depressive Symptoms' Alleviation and Quality of Life Improvement in Major Depressive Disorder: A Network Analysis Based on Longitudinal Data.揭示重度抑郁症中抑郁症状缓解与生活质量改善之间的相互作用：基于纵向数据的网络分析
Neuropsychiatr Dis Treat. 2024 Aug 30;20:1641-1654. doi: 10.2147/NDT.S462884. eCollection 2024.

本文引用的文献

1
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression.氯胺酮与电休克治疗非精神病性治疗抵抗性重性抑郁障碍。
N Engl J Med. 2023 Jun 22;388(25):2315-2325. doi: 10.1056/NEJMoa2302399. Epub 2023 May 24.
2
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.单次剂量裸盖菇素治疗难治性重度抑郁症发作。
N Engl J Med. 2022 Nov 3;387(18):1637-1648. doi: 10.1056/NEJMoa2206443.
3
Efficacy and Safety of Ketamine vs Electroconvulsive Therapy Among Patients With Major Depressive Episode: A Systematic Review and Meta-analysis.氯胺酮与电抽搐治疗在重度抑郁发作患者中的疗效和安全性：系统评价和荟萃分析。
JAMA Psychiatry. 2022 Dec 1;79(12):1162-1172. doi: 10.1001/jamapsychiatry.2022.3352.
4
Racemic Ketamine as an Alternative to Electroconvulsive Therapy for Unipolar Depression: A Randomized, Open-Label, Non-Inferiority Trial (KetECT).消旋体氯胺酮作为单相抑郁电抽搐治疗的替代疗法：一项随机、开放标签、非劣效性试验（KetECT）。
Int J Neuropsychopharmacol. 2022 May 27;25(5):339-349. doi: 10.1093/ijnp/pyab088.
5
Prevalence of depressive disorders and treatment in China: a cross-sectional epidemiological study.中国抑郁障碍的患病率及治疗状况：一项横断面流行病学研究。
Lancet Psychiatry. 2021 Nov;8(11):981-990. doi: 10.1016/S2215-0366(21)00251-0. Epub 2021 Sep 21.
6
A systematic review and meta-analysis of the efficacy of intravenous ketamine infusion for treatment resistant depression: January 2009 - January 2019.静脉注射氯胺酮治疗难治性抑郁症的系统评价和荟萃分析：2009 年 1 月至 2019 年 1 月。
J Affect Disord. 2020 Dec 1;277:831-841. doi: 10.1016/j.jad.2020.09.007. Epub 2020 Sep 7.
7
BDNF and the Antidepressant Effects of Ketamine and Propofol in Electroconvulsive Therapy: A Preliminary Study.脑源性神经营养因子以及氯胺酮和丙泊酚在电休克治疗中的抗抑郁作用：一项初步研究。
Neuropsychiatr Dis Treat. 2020 Apr 5;16:901-908. doi: 10.2147/NDT.S248190. eCollection 2020.
8
Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study.灵活剂量依他佐辛鼻喷雾剂联合新起始口服抗抑郁药治疗难治性抑郁症的疗效和安全性：一项随机、双盲、活性对照研究。
Am J Psychiatry. 2019 Jun 1;176(6):428-438. doi: 10.1176/appi.ajp.2019.19020172. Epub 2019 May 21.
9
Adjunctive ketamine and electroconvulsive therapy for major depressive disorder: A meta-analysis of randomized controlled trials.辅助性氯胺酮和电休克疗法治疗重性抑郁症：随机对照试验的荟萃分析。
J Affect Disord. 2019 May 1;250:123-131. doi: 10.1016/j.jad.2019.02.044. Epub 2019 Feb 18.
10
Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses. Final order.神经学设备；电休克治疗设备的重新分类；特定预期用途的电休克治疗设备上市前批准要求的生效日期。最终命令。
Fed Regist. 2018 Dec 26;83(246):66103-24.